For centuries, itch was categorized as a submodality of pain. Recent research over the last
decade has led to the realization that itch is in fact a separate and distinct, albeit closely …

There are remarkable differences in the diagnostic and therapeutic management of atopic
dermatitis practiced by dermatologists and pediatricians in different countries. Therefore, the …

Atopic dermatitis (AD) is a highly pruritic, chronic inflammatory skin disease. The diagnosis
is made using evaluated clinical criteria. Disease activity and burden are best measured …

Atopic dermatitis (AD) is a clinically defined, highly pruritic, chronic inflammatory skin
disease of children and adults. The diagnosis is made using evaluated clinical criteria …

The existing evidence for treatment of atopic eczema (atopic dermatitis, AE) is evaluated
using the national standard Appraisal of Guidelines Research and Evaluation. The …

Objective–To test the reliability of the eczema area and severity index (EASI) scoring system
by assessing inter‐and intra‐observer consistency. Design: Training of evaluators …

Guidelines/Outcomes Task Force: Abby Van Voorhees, MD, Chair Task Force, Mark A.
Bechtel, MD, Boni E. Elewski, MD, Steven R. Feldman, MD, Cindy Francyn Hoffman, MD …

Background The diagnosis of atopic dermatitis (AD) is made using evaluated clinical criteria.
Management of AD must consider the symptomatic variability of the disease. Methods EADV …

Objective To determine the efficacy and tolerability of topical pimecrolimus and tacrolimus
compared with other treatments for atopic dermatitis. Design Systematic review and meta …

Objective. Pimecrolimus cream (SDZ ASM 981), a nonsteroid inhibitor of inflammatory
cytokines, is effective in atopic dermatitis (AD). We assessed whether early treatment of AD …